LUIS POLO: Open Payments
NPI 1831624899 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,829 in 65 payments from 17 companies in 2025. Trend: 2023 $22,968 · 2024 $16,002 · 2025 $6,829
Speaker / faculty: $4,600Food & beverage: $1,755Travel & lodging: $465Education: $9
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 21 | $5,327 |
| Ardelyx, Inc. | 6 | $224 |
| Travere Therapeutics, Inc. | 7 | $215 |
| Otsuka America Pharmaceutical, Inc. | 5 | $209 |
| Mallinckrodt Hospital Products Inc. | 6 | $149 |
| Novartis Pharmaceuticals Corporation | 2 | $143 |
| Baxter Healthcare | 1 | $128 |
| Averitas Pharma Inc. | 3 | $94 |
| Novo Nordisk Inc | 3 | $74 |
| Vifor Pharma, Inc. | 1 | $64 |
Products named: KRYSTEXXA, Filspari, IBSRELA, Renal - Acute, ACTHAR, QUTENZA, XPHOZAH 30 MG, JYNARQUE.
Industry payments across GA — which companies pay providers there.
